Estimates Revisions Vivoryon Therapeutics N.V.
Stocks
VVY
NL00150002Q7
Biotechnology & Medical Research
|
Real-time
Euronext Amsterdam
03:00:06 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 1.105 EUR | +0.45% |
|
+0.45% | -22.18% |
| 08-06 | Vivoryon Therapeutics N.V., H1 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Vivoryon Therapeutics N.V. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- VVY Stock
- Consensus Vivoryon Therapeutics N.V.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
